TICAM2 and cervical squamous cell carcinoma: In summary, we constructed a novel necroptosis-related gene signature, which includes CAMK2A, CYBB, IL1A, IL1B, SLC25A5, and TICAM2, for predicting the prognosis of CESC patients.